2018
Percutaneous Management of Upper Tract Urothelial Carcinoma
Pan S, Motamedinia P. Percutaneous Management of Upper Tract Urothelial Carcinoma. 2018, 384-389. DOI: 10.1002/9781119245193.ch31.ChaptersUpper tract urothelial carcinomaUrothelial carcinomaLow-risk diseaseRare urologic malignancyStandard retrograde approachPatient risk stratificationPercutaneous tumor resectionRadical surgeryRisk stratificationTreatment algorithmAccurate stagingPercutaneous managementUrologic malignanciesTumor resectionBladder cancerRetrograde approachBiopsy capabilityPatientsCarcinomaDiseaseResectionSurgeryMalignancyCancerStaging
2015
The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience
Motamedinia P, Keheila M, Leavitt DA, Rastinehad AR, Okeke Z, Smith AD. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience. Journal Of Endourology 2015, 30: 262-267. PMID: 26630130, DOI: 10.1089/end.2015.0248.Peer-Reviewed Original ResearchMeSH KeywordsAdjuvants, ImmunologicAdultAge FactorsAgedAged, 80 and overAntibiotics, AntineoplasticBCG VaccineCarcinoma, Transitional CellDisease ProgressionEndoscopyFemaleHumansKidney NeoplasmsKidney PelvisMaleMiddle AgedMitomycinMultivariate AnalysisNeoplasm GradingNeoplasm Recurrence, LocalNeoplasm StagingNephrectomyRetrospective StudiesRisk FactorsSurvival RateUreterUreteral NeoplasmsConceptsUpper tract urothelial carcinomaBacillus Calmette-GuérinRadical nephroureterectomyOverall survivalUrothelial carcinomaPredictors of OSLow-risk patientsMajority of patientsRisk of deathLow-grade patientsGold standard treatmentHigh-grade patientsMonths of surveillanceResectable diseaseInitial resectionEndoscopic resectionImperative indicationsMedian timeRenal preservationTumor characteristicsAdjuvant rolePercutaneous resectionRetrospective studyPercutaneous managementStandard treatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply